Roche Appeals Preliminary Injunction Barring Mircera
Swiss drugmaker Roche Holding AG is seeking to overturn a preliminary injunction in its ongoing patent dispute with Amgen Inc. that bars Roche from selling anemia drug Mircera in the United...To view the full article, register now.
Already a subscriber? Click here to view full article